Ohr Pharmaceutical, Inc. (NBSE)

Last Year

07-May-23 -- 06-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

11

0

1

+1

0

+2

0

+3

Two Year Chart

07-May-22 -- 06-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
04-Aug-23 4:39 PM View:	02-Aug-23 Option Exercise $2.05K	Stephan Dietrich A Founder and CEO Director 10% Owner		Ohr Pharmaceutical, Inc. - NBSE	68% 137.28K to 230.51K	0	0	--	--	Show Txns Hide Txns

20-Sep-23 10:00 PM View:	18-Sep-23 Disposition (other) 0	Symetryx Corp		Ohr Pharmaceutical, Inc. - NBSE	(69%) 619.0K to 192.48K	0	0	--	--	Show Txns Hide Txns